Literature DB >> 11352579

Antibody recognition of a conformational epitope in a peptide antigen: Fv-peptide complex of an antibody fragment specific for the mutant EGF receptor, EGFRvIII.

R C Landry1, A C Klimowicz, S J Lavictoire, S Borisova, D T Kottachchi, I A Lorimer, S V Evans.   

Abstract

Epitope mapping studies and the determination of the structure to 1.8 A resolution have been carried out for the antigen-binding fragment MR1 in complex with peptide antigen. MR1 is specific for the novel fusion junction of the mutant epidermal growth factor receptor EGFRvIII and has been reported to have a high degree of specificity for the mutant EGFRvIII over the wild-type EGF receptor. The structure of the complex shows that the peptide antigen residue side-chains found by epitope mapping studies to be critical for recognition are accommodated in pockets on the surface of the Fv. However, the most distinctive portion of the peptide antigen, the novel fusion glycine residue, makes no contact to the Fv and does not contribute directly to the epitope. The specificity of MR1 lies in the ability of this glycine residue to assume the restricted conformation needed to form a type II' beta-hairpin turn more easily, and demonstrates that a peptide antigen can be used to generate a conformational epitope. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352579     DOI: 10.1006/jmbi.2001.4628

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   6.151


  7 in total

1.  Interfacial metal and antibody recognition.

Authors:  Tongqing Zhou; Dean H Hamer; Wayne A Hendrickson; Quentin J Sattentau; Peter D Kwong
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-29       Impact factor: 11.205

2.  The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen.

Authors:  Jonathan M Wojciak; Norman Zhu; Karen T Schuerenberg; Kelli Moreno; William S Shestowsky; Masao Hiraiwa; Roger Sabbadini; Tom Huxford
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

3.  Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.

Authors:  Bryan D Choi; Patrick C Gedeon; Chien-Tsun Kuan; Luis Sanchez-Perez; Gary E Archer; Darell D Bigner; John H Sampson
Journal:  J Immunol Methods       Date:  2013-06-24       Impact factor: 2.303

4.  Development of an EGFRvIII specific recombinant antibody.

Authors:  Puja Gupta; Shuang-Yin Han; Marina Holgado-Madruga; Siddhartha S Mitra; Gordon Li; Ryan T Nitta; Albert J Wong
Journal:  BMC Biotechnol       Date:  2010-10-07       Impact factor: 2.563

5.  Nature-inspired design of motif-specific antibody scaffolds.

Authors:  James T Koerber; Nathan D Thomsen; Brett T Hannigan; William F Degrado; James A Wells
Journal:  Nat Biotechnol       Date:  2013-08-18       Impact factor: 54.908

6.  Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies.

Authors:  Kristina Ellwanger; Uwe Reusch; Ivica Fucek; Stefan Knackmuss; Michael Weichel; Thorsten Gantke; Vera Molkenthin; Eugene A Zhukovsky; Michael Tesar; Martin Treder
Journal:  Front Oncol       Date:  2017-05-19       Impact factor: 6.244

7.  Ion Binding Properties of a Naturally Occurring Metalloantibody.

Authors:  Elinaz Farokhi; Jonathan K Fleming; M Frank Erasmus; Aaron D Ward; Yunjin Wu; Maria G Gutierrez; Jonathan M Wojciak; Tom Huxford
Journal:  Antibodies (Basel)       Date:  2020-04-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.